MiR-126 enhances cisplatin chemosensitivity in hepatocellular carcinoma cells by targeting IRS1

  • Jian Zuo
  • Rui Luo
  • Chenjie Huang
  • Xiaobin Lou
  • Lanjuan Li
Keywords: miR-126, IRS1, HCC, cisplatin, chemosensitivity

Abstract

Purpose: To investigate the potential role of miR-126 in regulating the proliferation and cisplatin chemosensitivity of human hepatocellular carcinoma (HCC) cells.
Methods: The expression of miR-126 was evaluated using clinical HCC specimens. MiR-126-mediated downregulation of Insulin Receptor Substrate 1 (IRS1) was determined by qRT-PCR, western blot and luciferase reporter assay. Cell Counting Kit-8 (CCK8) and colony formation assays were performed to examine the proliferation of HCC cells.
Results: Decreased expression of miR126 was found in HCC tumors and was correlated with poor survival in HCC patients. In HCC cells, miR-126 targeted IRS1 for downregulation, through which miR- 126 suppressed the growth of HCC cells and desensitized HCC cells to cisplatin treatment.
Conclusion: MiR-126a impairs the proliferation and cisplatin chemoresistance of HCC cells by targeting IRS1.

Keywords: miR-126, IRS1, HCC, cisplatin, chemosensitivity

Section
Articles

Journal Identifiers


eISSN: 1596-9827
print ISSN: 1596-5996